Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Level 3 contingent consideration liabilities by Year
Level 3 contingent consideration liabilities ($M) ($M)
Gilead Sciences Level 3 contingent consideration liabilities: $278M in FY2025, up 35.0% from a year earlier.
Where the FY2025 figure comes from
“|| Contingent consideration liability | $ | — | $ | — | $ | 60 | $ | 60 | $ | — | $ | — | $ | 278 | $ | 278”
Source: Form 10-Q (gild-20260630.htm, filed 2026-08-06) ↗
Reported in Form 10-Q / 10-K Note 3 Fair Value Measurements.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Level 3 contingent consideration liabilities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 278 | +35.0% | Form 10-Q (gild-20260630.htm, filed 2026-08-06) ↗ |
| FY2024 | Dec 31, 2024 | 206 | -9.6% | Form 10-K (gild-20251231.htm, filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 228 | -17.1% | Form 10-K (gild-20241231.htm, filed 2025-02-28) ↗ |
| FY2022 | Dec 31, 2022 | 275 | -13.2% | Form 10-K (filed 2024-02-23) ↗ |
| FY2021 | Dec 31, 2021 | 317 | – | Form 10-K (filed 2023-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 0 | – | Form 10-K (filed 2022-02-23) ↗ |
| FY2014 | Dec 31, 2014 | 133 | – | Form 10-Q (filed 2015-05-08) ↗ |
Breakdown
What makes up level 3 contingent consideration liabilities
Cite this data
StockData. (2026). Gilead Sciences Level 3 contingent consideration liabilities ($M), annual FY2014–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/cc-liab-tot
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.